Common Contracts
10 similar Restricted Stock Unit Grant Agreement contracts by Arena Pharmaceuticals Inc
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 19th, 2020 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of __________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and __________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • August 7th, 2018 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of ________________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ______________ (the “Participant”).
Restricted Stock Unit Grant AgreementRestricted Stock Unit Grant Agreement • June 22nd, 2017 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of ________________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ______________ (the “Participant”).
Restricted Stock Unit Grant Agreement for Non-Employee DirectorsRestricted Stock Unit Grant Agreement • June 22nd, 2017 • Arena Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS GRANT AGREEMENT (this “Agreement”), effective as of ________________ (the “Grant Date”), is entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ______________ (the “Participant”).
